Anthony Hunt - Nov 21, 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Marc Baumgartner (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Nov 21, 2024
Transactions value $
-$2,565,227
Form type
4
Date filed
11/22/2024, 04:52 PM
Previous filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $821K +24.2K +17.34% $33.87 164K Nov 21, 2024 Direct
transaction RGEN Common Stock Sale -$3.39M -24.2K -14.78% $139.67 140K Nov 21, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +24.2K $0.00 0 Nov 21, 2024 Common Stock 24.2K $33.87 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction undertaken consistent with a previously arranged transaction under the reporting person's Rule 10(b)5-1 trading plan, which expired on November 15, 2024.
F2 $139.67 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.25 to $140.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 This option is fully vested and exercisable.

Remarks:

Exhibit 24.1: Power of Attorney